The CDK4/6 inhibitor Palbociclib synergizes with ATRA to induce differentiation in AML.
Hu L, Li Q, Wang J, Wang H, Ren X, Huang K, Wang Y, Liang X, Pu L, Xiong S, Zhai Z.
Hu L, et al. Among authors: wang h, wang j, wang y.
Mol Cancer Ther. 2024 Mar 20. doi: 10.1158/1535-7163.MCT-23-0528. Online ahead of print.
Mol Cancer Ther. 2024.
PMID: 38507743